MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DarioHealth Corp. - Common Stock (NQ:DRIO)

11.00 +0.06 (+0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DarioHealth Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Schedules Release of Q2 2023 Results, Conference Call and Webcast
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Behavior Program to Support Weight Loss, Better Health
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Shares New Research Supporting Significant Medical Costs Savings for Dario Users
Via Investor Brand Network
News headline image
Recap: DarioHealth Q1 Earnings ↗
 
Via Benzinga
News headline image
DarioHealth's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Earnings Preview: DarioHealth ↗
 
Via Benzinga
News headline image
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. 
Via Benzinga
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Large Regional Health Plan to Client List, Reports on Q2 2023 Preliminary Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds New Full-Suite Employer to Growing Number of Contracts
Via Investor Brand Network
Topics Economy
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Key Research Presented at ABA Scientific Sessions
Via Investor Brand Network
News headline image
DarioHealth is an AI-Powered Digital Therapeutics Play
DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic 
Via MarketBeat
Topics Artificial Intelligence
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Two New Contracts for Integrated Solutions
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO to Present at Upcoming Stifel Virtual Cross Sector Insight Conference
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Launches Solutions to MedOne Members
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q1 Financial and Operating Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Research Presented at Leading Global Conference for Health Economics
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Upcoming Release of Q1 2023 Financial Results, Schedules Earnings Call
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Private Placement Pricing, Announces Credit Facility Refinance
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Appoints Digital Health Product Leader as Chief Product Officer
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Digital Therapeutics Contract with Top-10 PBM
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Amwell to Offer Valuable Access to Cardiometabolic Digital Therapeutic Solution
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Study Results Published, Shows Potential for Digital Therapeutics in Pain Management
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q4 and FY 2022 Results
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Date for Execs to Host Q4 2022 Results Call
Via Investor Brand Network
News headline image
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform. 
Via News Direct
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Clinical Outcomes in Two New Studies at Diabetes Conference
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) DarioHealth to Participate in Upcoming Cowen Health Care Conference
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Board Appointment of Health Care Industry Veteran
Via Investor Brand Network
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
Via Investor Brand Network
News headline image
CVS Deal To Buy Oak Street At $39 Per Share Brings Arbitrage Opportunity, Says StoryTrading's Rabizadeh ↗
Healthcare giant CVS Health Corp. (NYSE: CVS) announced on Wednesday a definitive agreement to buy primary healthcare provider Oak Street Health Inc. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story